PAVmed (PAVM) Notes Payables (2020 - 2023)
PAVmed (PAVM) posted quarterly Notes Payables of $291000.0 for Q3 2023, up 11.92% quarter-over-quarter from $260000.0 in Q2 2023.
PAVmed (PAVM) Notes Payables (2020 - 2023) Analysis & Trends
PAVmed's Notes Payables history runs 3 years deep, the most recent figure standing at $291000.0 for Q3 2023.
- In Q3 2023, Notes Payables changed N/A year-over-year to $291000.0; the TTM figure through Sep 2023 stood at $291000.0 (changed N/A YoY), while the FY2020 annual figure was $300000.0, changed N/A from the prior year.
- Notes Payables for Q3 2023 stood at $291000.0, up from $260000.0 in the prior quarter.
- The five-year high for Notes Payables was $300000.0 in Q4 2020, with the low at $150000.0 in Q2 2020.
- The 3-year median for Notes Payables is $275500.0 (2023), against an average of $250166.7.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 291,000.00 |
| Jun 30, 2023 | 260,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 300,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 150,000.00 |